These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9676073)
1. Botulinum treatment for post-stroke spasticity: low dose regime. Viriyavejakul A; Vachalathiti R; Poungvarin N J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073 [TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Slawek J; Bogucki A; Reclawowicz D Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach]. Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160 [TBL] [Abstract][Full Text] [Related]
5. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials. Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291 [TBL] [Abstract][Full Text] [Related]
6. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity. Suputtitada A; Suwanwela NC Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048 [TBL] [Abstract][Full Text] [Related]
7. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Mayer NH; Whyte J; Wannstedt G; Ellis CA Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749 [TBL] [Abstract][Full Text] [Related]
8. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes. Ashford S; Turner-Stokes L Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366 [TBL] [Abstract][Full Text] [Related]
9. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients. Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report. Opara J; Hordyńska E; Swoboda A Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426 [TBL] [Abstract][Full Text] [Related]
11. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of spasticity in cerebral palsy with botulinum toxin]. Calderón-González R; Calderón-Sepúlveda RF Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy. Kaishou Xu ; Tiebin Yan ; Jianning Mai Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Kong KH; Neo JJ; Chua KS Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238 [TBL] [Abstract][Full Text] [Related]
15. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study. Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837 [TBL] [Abstract][Full Text] [Related]
16. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573 [TBL] [Abstract][Full Text] [Related]
17. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724 [TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184 [TBL] [Abstract][Full Text] [Related]
19. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937 [TBL] [Abstract][Full Text] [Related]
20. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]. Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]